Track the Cresco Labs Inc. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares trade on the CA market, under the oversight of SEDI. Operating in the Health Care sector, Cresco Labs Inc. has logged 53 public disclosures. Market capitalisation: €402.1m. The latest transaction was disclosed on 21 September 2026 (57 - Exercise of rights). Among the most active insiders: Butler, Gregory Randolph. All data is free.
53
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,790 of 29,114 companies
29.4
score / 100
Value
30
Quality
29
FCF yld9.1%
Earn yld-35%
EV/EBITDA47.5x
ROE-36%
Gross mgn49%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
5,000 shares@ CA$0.780.0010% mcap1.2% of flowSubordinate Voting SharesTSXSEDI:4775811
Canonical exit: 3 Dec 2026 (T+90)
25 of 53 declarations
About Cresco Labs Inc.
Cresco Labs Inc. is a company in the health and pharmaceutical sector, focused on the production and distribution of cannabis-based products. It is listed on the Toronto Stock Exchange (XTSE).